BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37397565)

  • 21. The role of circadian clocks in cancer: Mechanisms and clinical implications.
    Liu H; Liu Y; Hai R; Liao W; Luo X
    Genes Dis; 2023 Jul; 10(4):1279-1290. PubMed ID: 37397565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of circadian clock genes in colorectal carcinoma: Novel insights into regulatory mechanism and implications in clinical therapy.
    Zhu H; Chen J; Wen Z; Li J; Yu Q; Liao W; Luo X
    Life Sci; 2023 Nov; 333():122145. PubMed ID: 37797685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronopharmacological strategies focused on chrono-drug discovery.
    Ohdo S; Koyanagi S; Matsunaga N
    Pharmacol Ther; 2019 Oct; 202():72-90. PubMed ID: 31173839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional and post-transcriptional regulation of the circadian clock of cyanobacteria and Neurospora.
    Brunner M; Schafmeier T
    Genes Dev; 2006 May; 20(9):1061-74. PubMed ID: 16651653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian clock and cell cycle: Cancer and chronotherapy.
    Yao J; He C; Zhao W; Hu N; Long D
    Acta Histochem; 2021 Dec; 123(8):151816. PubMed ID: 34800857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-talk between the circadian clock and the cell cycle in cancer.
    Soták M; Sumová A; Pácha J
    Ann Med; 2014 Jun; 46(4):221-32. PubMed ID: 24779962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PGC1α-mediated fatty acid oxidation promotes TGFβ1-induced epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma.
    Quan J; Li N; Tan Y; Liu H; Liao W; Cao Y; Luo X
    Life Sci; 2022 Jul; 300():120558. PubMed ID: 35452637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGFβ1-induced epithelial-mesenchymal transition and metastasis of colorectal carcinoma.
    Quan J; Cheng C; Tan Y; Jiang N; Liao C; Liao W; Cao Y; Luo X
    Int J Biol Sci; 2022; 18(6):2484-2496. PubMed ID: 35414781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
    Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM; Lawson DH; Khan MK; Kudchadkar RR; Buchwald ZS
    Lancet Oncol; 2021 Dec; 22(12):1777-1786. PubMed ID: 34780711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
    Quan J; Bode AM; Luo X
    Eur J Pharmacol; 2021 Oct; 909():174397. PubMed ID: 34332918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging roles of exosomal miRNAs in nasopharyngeal carcinoma.
    Liao C; Liu H; Luo X
    Am J Cancer Res; 2021; 11(6):2508-2520. PubMed ID: 34249413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the clock gene TIMELESS by H3k27 acetylation promotes colorectal cancer tumorigenesis by binding to Myosin-9.
    Cao M; Wang Y; Xiao Y; Zheng D; Zhi C; Xia X; Yuan X
    J Exp Clin Cancer Res; 2021 May; 40(1):162. PubMed ID: 33971927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RIP3 mediates TCN-induced necroptosis through activating mitochondrial metabolism and ROS production in chemotherapy-resistant cancers.
    Zhao X; Quan J; Tan Y; Liu Y; Liao C; Li Z; Liao W; Liu J; Cao Y; Luo X
    Am J Cancer Res; 2021; 11(3):729-745. PubMed ID: 33791150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging roles of dehydrogenase/reductase member 2 (DHRS2) in the pathology of disease.
    Li Z; Liu H; Bode A; Luo X
    Eur J Pharmacol; 2021 May; 898():173972. PubMed ID: 33652058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microglial Exosome miR-7239-3p Promotes Glioma Progression by Regulating Circadian Genes.
    Li X; Guan J; Jiang Z; Cheng S; Hou W; Yao J; Wang Z
    Neurosci Bull; 2021 Apr; 37(4):497-510. PubMed ID: 33528793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer.
    Wang Z; Li F; Wei M; Zhang S; Wang T
    Cancer Manag Res; 2020; 12():11897-11908. PubMed ID: 33244267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigallocatechin‑3‑gallate inhibits self‑renewal ability of lung cancer stem‑like cells through inhibition of CLOCK.
    Jiang P; Xu C; Zhang P; Ren J; Mageed F; Wu X; Chen L; Zeb F; Feng Q; Li S
    Int J Mol Med; 2020 Dec; 46(6):2216-2224. PubMed ID: 33125096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TIMELESS regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer.
    Zhang S; Huang P; Dai H; Li Q; Hu L; Peng J; Jiang S; Xu Y; Wu Z; Nie H; Zhang Z; Yin W; Zhang X; Lu J
    Cell Death Dis; 2020 Oct; 11(10):892. PubMed ID: 33093451
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.